Siemens Healthineers will invest around $300 million in its Walpole, Mass, laboratory diagnostics manufacturing and research and development facility. The investment is slated to extend over 4 years.

Dr. Bernd Montag

Bernd Montag, Siemens Healthineers.

“Expansion of the Walpole facility fits into the strategic growth plans for the company and allows us to increase our manufacturing footprint in the United States, the largest healthcare market in the world,” says Bernd Montag, CEO of Siemens Healthineers. ”The laboratory instruments and reagents developed and manufactured at the Siemens Healthineers Walpole facility impact patients and healthcare providers across the globe.”

The Walpole facility currently employs more than 700 employees and is the main manufacturing facility for assays that run on the Advia Centaur family of immunoassay instruments, and for consumables for the company’s molecular and blood gas testing instruments. The facility will also manufacture assays to run on the immunoassay module of the Atellica system, which is currently under FDA review. Research and development efforts at the site bring new tests to the diagnostics market to help physicians diagnose and treat disease.

Franz Walt, MBA, Siemens Healthineers.

Franz Walt, MBA, Siemens Healthineers.

“With a 37-year history of manufacturing products in Walpole, we saw an opportunity to leverage the local talent in the community to further our growth and expansion plans,” says Franz Walt, president of laboratory diagnostics at Siemens Healthineers.

The company plans to upgrade and expand its existing 500,000-square-foot complex. The expansion—which will include manufacturing, warehouse, office, and lab space—is set to begin in the summer. Siemens Healthineers is committed to creating at least 400 positions. The company anticipates that it may ultimately create up to as many as 700 new permanent jobs to bring the total employment at the site to between 1,300 and 1,600 by 2026.

“I am proud that Siemens has chosen to grow its laboratory diagnostics unit in Massachusetts,” says Gov. Charlie Baker. “The commonwealth is pleased to continue building a pro-growth economic environment that creates more jobs for our communities, and remains focused on supporting globally competitive life sciences and advanced manufacturing. I thank Siemens Healthineers for their commitment to Massachusetts, and look forward to continuing to partner with the company to move this important economic development project forward.”

For more information, visit Siemens Healthineers.